1996
DOI: 10.1002/(sici)1096-8652(199604)51:4<255::aid-ajh1>3.0.co;2-v
|View full text |Cite
|
Sign up to set email alerts
|

Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation

Abstract: Plasma-soluble fibrin monomer (SFM) level in patients with disseminated intravascular coagulation (DIC) was significantly higher than the level in patients with pre-DIC or in non-DIC patients, and the level in patients with pre-DIC was significantly higher than that in non-DIC patients. There was no significant difference in plasma SFM levels among various diseases underlying DIC. Plasma SFM level in patients with good outcome was significantly decreased after treatment for DIC. The sensitivity of fibrin degra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
56
0
1

Year Published

1998
1998
2012
2012

Publication Types

Select...
9

Relationship

7
2

Authors

Journals

citations
Cited by 77 publications
(61 citation statements)
references
References 19 publications
4
56
0
1
Order By: Relevance
“…Since the establishment of the Japanese diagnostic criteria for DIC by the JMHW [6] in 1987, many reports evaluated the efficacy of various drugs for DIC and the diagnostic usefulness of hemostatic molecular markers in DIC [8,11,19,21]. On the other hand, the ISTH/SSC meeting established the international diagnostic criteria for overt DIC [19] by modifying the JMHW diagnostic criteria.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Since the establishment of the Japanese diagnostic criteria for DIC by the JMHW [6] in 1987, many reports evaluated the efficacy of various drugs for DIC and the diagnostic usefulness of hemostatic molecular markers in DIC [8,11,19,21]. On the other hand, the ISTH/SSC meeting established the international diagnostic criteria for overt DIC [19] by modifying the JMHW diagnostic criteria.…”
Section: Discussionmentioning
confidence: 99%
“…The Japanese criteria are based on a scoring system based on the presence of underlying disease, bleeding, organ failure, and the results of global coagulation tests [fibrinogen, fibrin degradation products (FDP), platelet count, and prothrombin time (PT)]. Hemostatic molecular markers, such as D-dimer [7], soluble fibrin (SF) [8], thrombin-antithrombin complex (TAT) [9], plasmin-plasmin inhibitor complex (PPIC) [10], and thrombomodulin [11], can be also measured. However, the latter markers are very sensitive but not specific for DIC, and they cannot be measured in all hospitals.…”
Section: Introductionmentioning
confidence: 99%
“…D-dimer is reported to be a negative predictor for DVT and in Europe and North America, and D-dimer levels less than 0.5 mg/mL are indicative of absence of DVT/PE [16]. On the other hand, plasma levels of soluble fibrin (SF), produced by thrombin-catalyzed cleavage of fibrinogen, were reported to be significantly high in patients with DIC [18].…”
Section: Introductionmentioning
confidence: 99%
“…Both criteria are scoring systems based on global coagulation tests such as fibrinogen, fibrinogen/fibrin degradation products (FDP), platelet counts, and prothrombin time (PT). Hemostatic molecular markers such as D-dimers [7], soluble fibrin (SF) [8], thrombin-antithrombin complex (TAT) [9], plasmin-plasmin inhibitor complex (PPIC) [10], and thrombomodulin (TM) [11] can be also measured. However, these latter markers are very sensitive but not specific for DIC.…”
Section: Introductionmentioning
confidence: 99%